$TDOC
Teladoc Health, Inc.

2020 Q3 Form 10-Q Financial Statement

#000155837020008663 Filed on July 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q4
Revenue $288.8M $241.0M $156.5M
YoY Change 109.33% 85.01% 27.5%
Cost Of Revenue $104.7M $90.78M $55.36M
YoY Change 144.69% 118.04% 38.29%
Gross Profit $184.1M $150.3M $101.1M
YoY Change 93.43% 69.5% 22.27%
Gross Profit Margin 63.74% 62.34% 64.63%
Selling, General & Admin $83.23M $75.30M $61.23M
YoY Change 51.87% 38.47% 20.14%
% of Gross Profit 45.21% 50.12% 60.55%
Research & Development $29.96M $23.03M $16.25M
YoY Change 90.26% 38.19% 19.95%
% of Gross Profit 16.27% 15.33% 16.06%
Depreciation & Amortization $15.37M $11.43M $11.09M
YoY Change 34.59% 5.06% 16.13%
% of Gross Profit 8.35% 7.61% 10.97%
Operating Expenses $113.2M $98.33M $77.48M
YoY Change 60.44% 38.4% 20.1%
Operating Profit -$19.73M -$7.179M -$15.59M
YoY Change -1.1% -67.4% -12.61%
Interest Expense -$17.20M -$13.20M -$7.600M
YoY Change 123.38% 83.33% 13.43%
% of Operating Profit
Other Income/Expense, Net -$252.0K $111.0K
YoY Change
Pretax Income -$38.17M -$28.08M -$23.17M
YoY Change 38.09% -3.94% -5.43%
Income Tax -$2.300M -$2.400M -$4.125M
% Of Pretax Income
Net Earnings -$35.88M -$25.68M -$19.04M
YoY Change 76.37% -12.42% -23.45%
Net Earnings / Revenue -12.42% -10.66% -12.17%
Basic Earnings Per Share
Diluted Earnings Per Share -$429.4K -$335.9K -$261.7K
COMMON SHARES
Basic Shares Outstanding 81.23M 74.45M 72.38M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.190B $1.312B $517.1M
YoY Change 142.5% 177.56% 8.05%
Cash & Equivalents $1.187B $1.309B $514.4M
Short-Term Investments $3.070M $2.932M $2.711M
Other Short-Term Assets $22.00M $14.00M $14.00M
YoY Change 69.23% 40.0% 27.27%
Inventory $11.58M $0.00
Prepaid Expenses
Receivables $85.80M $76.90M $56.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.310B $1.403B $588.0M
YoY Change 134.79% 163.44% 10.37%
LONG-TERM ASSETS
Property, Plant & Equipment $20.36M $9.606M $10.30M
YoY Change 103.21% -1.19% 1.46%
Goodwill $1.691B $742.3M $746.1M
YoY Change 129.29% -0.77% 1.2%
Intangibles $386.6M $213.5M $225.5M
YoY Change 68.93% -10.81% -8.87%
Long-Term Investments
YoY Change
Other Assets $7.117M $19.88M $6.545M
YoY Change 11.78% 211.86% 367.17%
Total Long-Term Assets $2.139B $1.016B $1.015B
YoY Change 111.72% -1.65% 1.88%
TOTAL ASSETS
Total Short-Term Assets $1.310B $1.403B $588.0M
Total Long-Term Assets $2.139B $1.016B $1.015B
Total Assets $3.449B $2.419B $1.603B
YoY Change 119.93% 54.52% 4.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.41M $10.82M $9.075M
YoY Change 252.8% 77.92% 16.81%
Accrued Expenses $110.0M $81.00M $58.00M
YoY Change 103.7% 113.16% 41.46%
Deferred Revenue $24.81M $12.47M
YoY Change 101.98% 62.95%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.00M $0.00
YoY Change
Total Short-Term Liabilities $200.8M $123.5M $90.18M
YoY Change 135.7% 75.44% 44.43%
LONG-TERM LIABILITIES
Long-Term Debt $963.0M $948.0M $440.0M
YoY Change 121.89% 122.01% 6.02%
Other Long-Term Liabilities $1.033M $5.257M $9.239M
YoY Change -85.56% -24.79% 49.23%
Total Long-Term Liabilities $1.033M $5.257M $9.239M
YoY Change -85.56% -24.79% 49.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $200.8M $123.5M $90.18M
Total Long-Term Liabilities $1.033M $5.257M $9.239M
Total Liabilities $201.9M $128.8M $99.42M
YoY Change 118.56% 66.39% 44.86%
SHAREHOLDERS EQUITY
Retained Earnings -$598.7M -$562.8M -$507.5M
YoY Change 22.56% 20.22% 24.19%
Common Stock $2.835B $1.880B $1.539B
YoY Change 87.74% 26.72% 7.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.231B $1.295B $1.014B
YoY Change
Total Liabilities & Shareholders Equity $3.449B $2.419B $1.603B
YoY Change 119.93% 54.52% 4.84%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q4
OPERATING ACTIVITIES
Net Income -$35.88M -$25.68M -$19.04M
YoY Change 76.37% -12.42% -23.45%
Depreciation, Depletion And Amortization $15.37M $11.43M $11.09M
YoY Change 34.59% 5.06% 16.13%
Cash From Operating Activities $32.20M $35.55M $18.12M
YoY Change 138.7% 478.05% 630.65%
INVESTING ACTIVITIES
Capital Expenditures -$9.300M -$5.160M -$3.390M
YoY Change 182.67% 102.35% 16.1%
Acquisitions
YoY Change
Other Investing Activities -$146.2M -$4.500M $12.94M
YoY Change -987.43% 79.28% -132.82%
Cash From Investing Activities -$155.5M -$9.660M $9.540M
YoY Change -1277.73% 90.53% -122.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 420.0K 773.2M 10.04M
YoY Change -95.41% 14769.81% 34.77%
NET CHANGE
Cash From Operating Activities 32.20M 35.55M 18.12M
Cash From Investing Activities -155.5M -9.660M 9.540M
Cash From Financing Activities 420.0K 773.2M 10.04M
Net Change In Cash -122.8M 799.1M 37.70M
YoY Change -442.75% 12624.84% -216.29%
FREE CASH FLOW
Cash From Operating Activities $32.20M $35.55M $18.12M
Capital Expenditures -$9.300M -$5.160M -$3.390M
Free Cash Flow $41.50M $40.71M $21.51M
YoY Change 147.32% 367.93% 298.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72761941
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79099433
tdoc Number Of Service Corporations Consolidated As Variable Interest Entities
NumberOfServiceCorporationsConsolidatedAsVariableInterestEntities
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
dei Entity Central Index Key
EntityCentralIndexKey
0001477449
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37477
dei Entity Registrant Name
EntityRegistrantName
TELADOC HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3705970
dei Entity Address Address Line1
EntityAddressAddressLine1
2 Manhattanville Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Purchase
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10577
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
635-2002
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
TDOC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81228458
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1308843000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
514353000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2932000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2711000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5113000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3787000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76902000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56948000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14433000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13990000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1403110000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
588002000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9606000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10296000
CY2020Q2 us-gaap Goodwill
Goodwill
742314000
CY2019Q4 us-gaap Goodwill
Goodwill
746079000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
213474000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
225453000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30440000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26452000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19884000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6545000
CY2020Q2 us-gaap Assets
Assets
2418828000
CY2019Q4 us-gaap Assets
Assets
1602827000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10816000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9075000
CY2020Q2 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
75153000
CY2019Q4 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
46905000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37579000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34201000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
123548000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
90181000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5257000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11539000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27940000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24994000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18976000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
21678000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
421829000
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
948178000
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
440410000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79099433
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72761941
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
79000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
73000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1879573000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1538716000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-562810000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-507525000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21913000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17239000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1294929000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1014025000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2418828000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1602827000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
241030000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
130276000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
258849000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90780000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
163162000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
86311000
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
47578000
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
26616000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
80093000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
53020000
CY2020Q2 us-gaap Selling Expense
SellingExpense
18687000
CY2019Q2 us-gaap Selling Expense
SellingExpense
15832000
us-gaap Selling Expense
SellingExpense
36627000
us-gaap Selling Expense
SellingExpense
32044000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23029000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16665000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42286000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32652000
CY2020Q2 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
2232000
CY2019Q2 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
2019000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
3454000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
3605000
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1627000
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1136000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5291000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2148000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54383000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28190000
us-gaap Operating Income Loss
OperatingIncomeLoss
-44910000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7751000
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7751000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13151000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7211000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38549000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99503000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74531000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9893000
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9848000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19603000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19448000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
248209000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
152299000
us-gaap Costs And Expenses
CostsAndExpenses
450019000
us-gaap Costs And Expenses
CostsAndExpenses
303759000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7179000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22023000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22454000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13732000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28081000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29234000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58395000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58642000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2399000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3110000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
832000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-25682000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
us-gaap Net Income Loss
NetIncomeLoss
-55285000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76512870
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71721246
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
74919194
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71322586
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-25682000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
us-gaap Net Income Loss
NetIncomeLoss
-55285000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
5000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
60000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12880000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4311000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4674000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
468000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12880000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4316000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4674000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
528000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12802000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25008000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59959000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58946000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1014025000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14830000
CY2020Q1 tdoc Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
0
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
58000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18421000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17554000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-29603000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1000177000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18683000
CY2020Q2 tdoc Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
0
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2473000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
693806000
CY2020Q2 tdoc Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Extinguishment
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtExtinguishment
715151000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
285601000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22142000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12880000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-25682000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1294929000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1013119000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8854000
CY2019Q1 tdoc Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
0
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13523000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3788000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-30150000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1001558000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6847000
CY2019Q2 tdoc Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
0
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1875000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17368000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4316000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1002640000
us-gaap Net Income Loss
NetIncomeLoss
-55285000
us-gaap Net Income Loss
NetIncomeLoss
-59474000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22655000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1595000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1251000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-36000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-74000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1844000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
374000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
25208000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
10358000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1818000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9133000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22443000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2290000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1014000
us-gaap Share Based Compensation
ShareBasedCompensation
40243000
us-gaap Share Based Compensation
ShareBasedCompensation
30891000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-3457000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-1472000
tdoc Accretion Of Interest
AccretionOfInterest
16576000
tdoc Accretion Of Interest
AccretionOfInterest
12347000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7751000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24773000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7237000
tdoc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2788000
tdoc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-794000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-847000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2385000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29230000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1743000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1641000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1248000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
6449000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2975000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
22695000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13500000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11207000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21590000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2272000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33513000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15701000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1000000000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24070000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
tdoc Contingent Consideration Fair Value Adjustment Cash Flow Impact
ContingentConsiderationFairValueAdjustmentCashFlowImpact
0
tdoc Contingent Consideration Fair Value Adjustment Cash Flow Impact
ContingentConsiderationFairValueAdjustmentCashFlowImpact
210000
tdoc Payments For Repurchase Of Convertible Debt
PaymentsForRepurchaseOfConvertibleDebt
228130000
tdoc Payment Terms
PaymentTerms
P30D
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
241030000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
130276000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
421829000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
258849000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76900000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12300000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4600000
CY2020Q2 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
2400000
tdoc Payments For Repurchase Of Convertible Debt
PaymentsForRepurchaseOfConvertibleDebt
0
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2473000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1875000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
4492000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
-1886000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
788278000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15900000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
795918000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16429000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1428000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
514353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
423989000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1308843000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
440443000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
59000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
309000
us-gaap Interest Paid
InterestPaid
5609000
us-gaap Interest Paid
InterestPaid
6102000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Note 1. Organization and Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">Teladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is the global leader in providing virtual healthcare services with a focus on high quality, lower costs, and improved outcomes around the world.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On July 1, 2020, the Company completed the acquisition of InTouch Technologies, Inc., the leading provider of enterprise telehealth solutions for hospitals and health systems. See Note 15 “Subsequent Events”. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
tdoc Number Of Professional Associations Consolidated As Variable Interest Entities
NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities
2
tdoc Number Of Professional Corporations Consolidated As Variable Interest Entities
NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities
11
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:10pt 0pt 0pt 10.8pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">Certain prior year amounts have been reclassified to conform to the current year presentation.</p>
tdoc Contract With Customer Term
ContractWithCustomerTerm
P1Y
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
94343000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
225453000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000000.0
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000000.0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17900000
CY2019Q2 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
600000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
3700000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
1200000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
325931000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112457000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213474000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
319796000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17700000
CY2019Q4 us-gaap Goodwill
Goodwill
746079000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
10604000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-3765000
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1722000
CY2020Q2 us-gaap Goodwill
Goodwill
742314000
CY2019Q4 us-gaap Goodwill
Goodwill
746079000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1838000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1535000
CY2020Q2 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
18430000
CY2019Q4 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
10618000
CY2020Q2 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
3121000
CY2019Q4 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
3298000
CY2020Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1820000
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1077000
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2046000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
838000
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1790000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2859000
CY2020Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2480000
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1263000
CY2020Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3090000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2810000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5763000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5088000
CY2020Q2 tdoc Accrued Earn Out Current
AccruedEarnOutCurrent
5216000
CY2019Q4 tdoc Accrued Earn Out Current
AccruedEarnOutCurrent
0
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24813000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12466000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4746000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5053000
CY2020Q2 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
75153000
CY2019Q4 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
46905000
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2200000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21928000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17368000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40243000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30891000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21

Files In Submission

Name View Source Status
0001558370-20-008663-index-headers.html Edgar Link pending
0001558370-20-008663-index.html Edgar Link pending
0001558370-20-008663.txt Edgar Link pending
0001558370-20-008663-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdoc-20200630.xsd Edgar Link pending
tdoc-20200630ex211ce3dcd.htm Edgar Link pending
tdoc-20200630ex211ce3dcd001.jpg Edgar Link pending
tdoc-20200630ex311cb97a3.htm Edgar Link pending
tdoc-20200630ex31251d7ee.htm Edgar Link pending
tdoc-20200630ex32156c2ae.htm Edgar Link pending
tdoc-20200630ex32288d578.htm Edgar Link pending
tdoc-20200630x10q.htm Edgar Link pending
tdoc-20200630x10q_htm.xml Edgar Link completed
tdoc-20200630_cal.xml Edgar Link unprocessable
tdoc-20200630_def.xml Edgar Link unprocessable
tdoc-20200630_lab.xml Edgar Link unprocessable
tdoc-20200630_pre.xml Edgar Link unprocessable